Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AHRT
2976
AH Realty Trust
AHRT
$506M
| $1.5M | ﹤0.01% |
128,819
+8,757
| +7% | +$102K |
|
|
GTY
2977
Getty Realty Corp
GTY
$2.05B
| $1.5M | ﹤0.01% |
44,338
+1,574
| +4% | +$53.5K |
|
2978
Hanover Insurance
THG
$7.84B
| $1.5M | ﹤0.01% |
13,278
+165
| +1% | +$19.6K |
|
2979
Medifast
MED
$128M
| $1.5M | ﹤0.01% |
16,273
-9,547
| -37% | -$850K |
|
2980
Autohome
ATHM
$2.61B
| $1.5M | ﹤0.01% |
51,367
+32,397
| +171% | +$967K |
|
2981
Nuveen Select Tax-Free Income Portfolio
NXP
$902M
| $1.5M | ﹤0.01% |
103,913
-21,958
| -17% | -$317K |
|
2982
Cabaletta Bio
CABA
$466M
| $1.5M | ﹤0.01% |
115,805
+14,707
| +15% | +$160K |
|
2983
John Hancock Multifactor Emerging Markets ETF
JHEM
$1.03B
| $1.5M | ﹤0.01% |
60,458
-5,664
| -9% | -$138K |
|
2984
iShares Genomics Immunology and Healthcare ETF
IDNA
$208M
| $1.49M | ﹤0.01% |
63,969
+3,574
| +6% | +$85.7K |
|
2985
Fidelity MSCI Energy Index ETF
FENY
$2.09B
| $1.49M | ﹤0.01% |
67,349
+19,881
| +42% | +$439K |
|
2986
BioLife Solutions
BLFS
$1.72B
| $1.49M | ﹤0.01% |
67,419
+7,202
| +12% | +$152K |
|
|
RMT
2987
Royce Micro-Cap Trust
RMT
$781M
| $1.49M | ﹤0.01% |
170,221
+27,315
| +19% | +$230K |
|
2988
Sprouts Farmers Market
SFM
$7.69B
| $1.49M | ﹤0.01% |
40,591
-952
| -2% | -$33.2K |
|
2989
Sonos
SONO
$1.93B
| $1.49M | ﹤0.01% |
91,286
-22,717
| -20% | -$403K |
|
2990
State Street SPDR S&P Pharmaceuticals ETF
XPH
$518M
| $1.49M | ﹤0.01% |
36,325
-11,950
| -25% | -$493K |
|
2991
Global X Artificial Intelligence & Technology ETF
AIQ
$10.3B
| $1.49M | ﹤0.01% |
53,231
+23,357
| +78% | +$591K |
|
2992
Kyndryl
KD
$2.87B
| $1.49M | ﹤0.01% |
112,083
+52,055
| +87% | +$705K |
|
2993
iShares Morningstar Multi-Asset Income ETF
IYLD
$126M
| $1.49M | ﹤0.01% |
76,148
+5,040
| +7% | +$96.8K |
|
2994
Independence Realty Trust
IRT
$4.01B
| $1.48M | ﹤0.01% |
81,422
+5,788
| +8% | +$98.8K |
|
2995
BRC Group Holdings
RILY
$299M
| $1.48M | ﹤0.01% |
32,301
+3,552
| +12% | +$125K |
|
2996
Nuveen California Quality Municipal Income Fund
NAC
$1.86B
| $1.48M | ﹤0.01% |
135,777
-35,561
| -21% | -$384K |
|
2997
Enova International
ENVA
$6.61B
| $1.48M | ﹤0.01% |
27,884
+2,467
| +10% | +$116K |
|
2998
PUT
NIO
NIO
$11.3B
| $1.48M | ﹤0.01% |
152,800
| – | – |
|
2999
Schwab Fundamental International Large Company Index ETF
FNDF
$25.9B
| $1.48M | ﹤0.01% |
45,833
-285,500
| -86% | -$9.13M |
|
3000
Stock Yards Bancorp
SYBT
$2.64B
| $1.48M | ﹤0.01% |
32,622
+7
| +0% | +$328 |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.